Mergers and Acquisitions

Gene silencing company acquired for gene, protein studies

Published in Gene Therapy Weekly, October 30th, 2003

CalbaTech, Inc., (CLBE), which is focused on acquiring, incubating and developing early stage life science companies, announced that it has executed an agreement to acquire Molecula Research Laboratories, LLC (Molecula), Herndon, Virginia, a company in gene silencing technologies for gene and protein function studies. Terms of the transaction were not disclosed.

"CalbaTech's acquisition of Molecula, a private company, allows us to move forward with our strategic plan for the RNAi market," said Matt Maupin, CEO of Molecula. The company's technology permits delivery of active siRNA or antisense to target genes with a high rate of success. Design technology and experience...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry